{"name":"Vivoryon Therapeutics N.V.","slug":"vivoryon-therapeutics-n-v","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPeTkyTVVTOEZJRGtCUW9LNTBFeHVxQ3dYa1hmZ2JEb0lJcWFtblRsUnFXOFBwZElxZl9GQ2F5bVVrYXZCcVBCdDJha3FyQ2g1R1ZFOTFsRW4xOWpwRFBGRXZmWk1tcml0WDRZWkRMakRjTnFJT05VR0tuQV9tSVJnZFhraFFIU0RLbTQxMWpJZURuZ1IxRjJuYVdhZ3VlZjg0MHB5cldMX3Uza3JrV3plcjI5TDhqVWlTOWxNaHJBa2o0TUp3TXZIOHR3?oc=5","date":"2026-03-29","type":"pipeline","source":"Idéal Investisseur","summary":"Vivoryon Therapeutics: Promising Results Against Diabetic Kidney Disease - Idéal Investisseur","headline":"Vivoryon Therapeutics: Promising Results Against Diabetic Kidney Disease - Idéal Investisseur","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxORDdBLWxBeEZTdDhfN0k2U3dFcEI5TG1IOWE0V18zTU03WTdIZHFpenhZdFg5UXgxbkEtLWd2OFZPUUVXSGVrck1pRGhrSVpjTEd2ZW5DRVBBcTZaQXo5NTQ2bzQxa0Fza1puQ3Y5a1hBalMtNDdEdDBFcFA4R0xld2JSbHhITV9nSW1LTGs1Nk9vWUFhUTFQelFNZzRYYmpSSlEtVVdURGFfTElmWERMWExDWUI1OC1TMlk2UDNBUlJ2ZHdseTNWdHVqajJJWURlRGcyM0VzRFhPRGtCa0xnOVJvSHJ3TFU2dldKMlZZandGYjhjZkxHa1RjMk0wQkZvSEViV0JWcWk5ZlZWVUJDQlJubDBsMHNQcjJGWWw2ZXBsR09UcFJ0NEtFNDJiRkRVamw5VXBqdDh5Mmpmd09UR24xU3dDOHgyazZ2aWlFRVo5UQ?oc=5","date":"2026-03-28","type":"pipeline","source":"globenewswire.com","summary":"Vivoryon Therapeutics N.V. Provides Update on Growing Body - globenewswire.com","headline":"Vivoryon Therapeutics N.V. Provides Update on Growing Body","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQZzFxR2t2T0JUdDg4SzBaZFk5b1QyTnI1OU5vYkdfanJzcVE3Tm9kd2RRR09RdXc4NEhyTG5HMDdQTEotWTZwS21WenFCckpmcnYtb3FPM2Q5SUM0Z0l2bXBaUGwwSFBLQXQwa214RTM2SV9fTU5vUjNnM3JJNHR4Q25uLWNVWmdJd0tKMA?oc=5","date":"2025-10-06","type":"pipeline","source":"Yahoo Finance","summary":"Vivoryon Therapeutics N.V. Successfully Completes Private Placement Raising EUR 5.1 Million - Yahoo Finance","headline":"Vivoryon Therapeutics N.V. Successfully Completes Private Placement Raising EUR 5.1 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQMjZSWmpRcERqSHJNMExWZkNDekRvaFplY3UxcVFsMTZ4OHRfLW9yaXRQSjlxUmtlalpQWFNKZlVQTXVfOVJvUlVWV1RFVy1yeGYyNmJyVng2QTE4SVpaNFZiXzY5aXpOdFJKVE9tRFphbk9XWWlCR0JkSUp4MXptcjc3VmNSS0NDSzNtck9TSFhFZw?oc=5","date":"2025-06-02","type":"pipeline","source":"Via Ritzau","summary":"Zealand Pharma - Via Ritzau","headline":"Zealand Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQYjRvQ0FDUmtFUzJmUW5QYnQ3VDJsemVmcUllYXlWNEEycHl1TFFvQWh2TEVRZ1NPR0xyMElmMk5jUDBQNFJpNEVxQ3JZV3ctY00tSjFmUUIzQkJTT19LUFpzWkJSQlpmY3dXb01BYjNua05JTGZVRmdtdmpBLWdEbjRjX0VKTnpBUDVickJPUFRhQQ?oc=5","date":"2025-04-24","type":"pipeline","source":"Via Ritzau","summary":"Zealand Pharma - Via Ritzau","headline":"Zealand Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxPeHlGSmlDNGs0NnEyenZmaEdGdlc1SmFYUTZrTUk3eXFnempnTEh0dHpYc1JsUDJuZjh3MVowZDFaQllXZ2g5dTdhR3dSRFVNMkFNWXhmTG9GbnZkSEhmNXE4aG5nTzliNXFYUUR0NHE4R0VIY011RDk3YU5hZVJlWkxQZVVvSHZ5a18tYjNPWnRST3ZRNURia05tb2VJNElPN2FFeFRTWmlPOFdEbDg1OXhkN0pKOGNmU0owTkQxLTBaT2pPLW1KS2EwUExDRUtfNmgydWlUU3MzekdYSUZRVkdRbVdQdGhzRHJ2TE1oaGFRSDVzaElQN2ZWY1BaaWFFTURXTWlvRExaZw?oc=5","date":"2024-12-04","type":"earnings","source":"globenewswire.com","summary":"Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024 - globenewswire.com","headline":"Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPQTk1RjhIcHNLLWhTYVRZVmtIRUY0TjhlWG9lTmE1bERLbXZRTjlZa1k1c2xZY0hTUXV3bVhia19MZGRLM3NhVEFoMkkwUU8wdjNEeHVvRW9Ua25VeGRKQWlUbHJhMEFyeDhVLS1fem13QTRvTElTakFMRHlGWkR0amNsYm9QVFBHeUxR?oc=5","date":"2024-05-10","type":"trial","source":"openPR.com","summary":"Dementia Market 2032: Epidemiology Data, Pipeline - openPR.com","headline":"Dementia Market 2032: Epidemiology Data, Pipeline","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}